Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTEMIS: Darunavir/r vs Lopinavir/r in Treatment-Naive HIV-1
NCT00258557Phase 3Completed
- Sponsor
- Tibotec
- Start
- Sep 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 3 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Sep 2005; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00258557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258557.